CDSCO Limits Supply of IVF Consumables to Registered ART Clinics and Sperm Banks
The Central Drugs Standard Control Organisation (CDSCO) has directed that essential consumables used in in-vitro fertilisation (IVF) procedures can now…
The Central Drugs Standard Control Organisation (CDSCO) has directed that essential consumables used in in-vitro fertilisation (IVF) procedures can now…
India’s drug regulator is considering a proposal that would allow hospitals to directly import high-end medical equipment, eliminating the need…
A new under-the-skin immunotherapy treatment for lung cancer, Tecentriq (atezolizumab), has been launched in India, offering a much faster alternative…
The Centre has introduced revised recruitment rules for the Drugs Controller General of India (DCGI), aiming to fix long-standing issues…
In line with a recent judgment by the Supreme Court of India, the National Medical Commission (NMC) has directed all…
In a recent drug safety update, 60 batches of medicines and medical devices have been classified as Not of Standard…
Dr. Reddy’s Laboratories has entered the fast-growing GLP-1 therapy segment with the launch of its semaglutide generic, Obeda, for Type…
Novartis AG’s move to exit its small Indian subsidiary once again highlights the limited appetite of global pharmaceutical giants to…
India is facing a rising incidence of metabolic, degenerative and autoimmune disorders, largely due to changing lifestyles and increasing environmental…
The detection of a counterfeit batch of Abhayrab, a rabies vaccine manufactured by government-owned Indian Immunologicals Limited (IIL), has highlighted…